{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T19:29:52Z","timestamp":1792092592668,"version":"4.4.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T00:00:00Z","timestamp":1719532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T00:00:00Z","timestamp":1719532800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drugs Ther"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s10557-024-07590-0","type":"journal-article","created":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T05:02:31Z","timestamp":1719550951000},"page":"1453-1464","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Heme Oxygenase-1, Cardiac Senescence, and Myocardial Infarction: A Critical Review of the Triptych"],"prefix":"10.1007","volume":"39","author":[{"given":"Inderbir","family":"Padda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0345-3876","authenticated-orcid":false,"given":"Yashendra","family":"Sethi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maumita","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Fabian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tushar","family":"Ralhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Aziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Sexton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gurpreet","family":"Johal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,28]]},"reference":[{"key":"7590_CR1","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.ebiom.2018.11.056","volume":"39","author":"H Shan","year":"2019","unstructured":"Shan H, Li T, Zhang L, Yang R, et al. Heme oxygenase-1 prevents heart against myocardial infarction by attenuating ischemic injury-induced cardiomyocytes senescence. EBioMedicine. 2019;39:59\u201368. https:\/\/doi.org\/10.1016\/j.ebiom.2018.11.056.","journal-title":"EBioMedicine"},{"issue":"4","key":"7590_CR2","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1172\/JCI105360","volume":"45","author":"RF Coburn","year":"1966","unstructured":"Coburn RF, Williams WJ, Kahn SB. Endogenous carbon monoxide production in patients with hemolytic anemia. J Clin Investig. 1966;45(4):460\u20138. https:\/\/doi.org\/10.1172\/JCI105360.","journal-title":"J Clin Investig"},{"issue":"13","key":"7590_CR3","doi-asserted-by":"publisher","first-page":"9452","DOI":"10.1074\/jbc.M109.077230","volume":"285","author":"JZ He","year":"2010","unstructured":"He JZ, Ho JJD, Gingerich S, et al. Enhanced translation of heme oxygenase-2 preserves human endothelial cell viability during hypoxia. J Biol Chem. 2010;285(13):9452\u201361. https:\/\/doi.org\/10.1074\/jbc.M109.077230.","journal-title":"J Biol Chem."},{"issue":"19","key":"7590_CR4","doi-asserted-by":"publisher","first-page":"5216","DOI":"10.1093\/emboj\/cdf516","volume":"21","author":"J Sun","year":"2002","unstructured":"Sun J, Hoshino H, Takaku K, et al. Hemoprotein Bach1 regulates enhancer availability of heme oxygenase-1 gene. The EMBO J. 2002;21(19):5216\u201324. https:\/\/doi.org\/10.1093\/emboj\/cdf516.","journal-title":"The EMBO J"},{"issue":"2","key":"7590_CR5","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1161\/hh1401.093314","volume":"89","author":"SF Yet","year":"2001","unstructured":"Yet SF, Tian R, Layne MD, et al. Cardiac-specific expression of heme oxygenase-1 protects against ischemia and reperfusion injury in transgenic mice. Circulation research. 2001;89(2):168\u201373. https:\/\/doi.org\/10.1161\/hh1401.093314.","journal-title":"Circulation research"},{"issue":"12","key":"7590_CR6","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1161\/CIRCRESAHA.116.306588","volume":"118","author":"LE Otterbein","year":"2016","unstructured":"Otterbein LE, Foresti R, Motterlini R. heme oxygenase-1 and carbon monoxide in the heart: the balancing act between danger signaling and pro-survival. Circulation research. 2016;118(12):1940\u201359. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.306588.","journal-title":"Circulation research"},{"issue":"1\u20132","key":"7590_CR7","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/BF00227888","volume":"157","author":"HS Sharma","year":"1996","unstructured":"Sharma HS, Maulik N, Gho BC, et al. Coordinated expression of heme oxygenase-1 and ubiquitin in the porcine heart subjected to ischemia and reperfusion. Molecular and cellular biochemistry. 1996;157(1\u20132):111\u20136. https:\/\/doi.org\/10.1007\/BF00227888.","journal-title":"Molecular and cellular biochemistry"},{"issue":"1","key":"7590_CR8","doi-asserted-by":"publisher","first-page":"H48","DOI":"10.1152\/ajpheart.00741.2006","volume":"293","author":"X Liu","year":"2007","unstructured":"Liu X, Simpson JA, Brunt KR, et al. Preemptive heme oxygenase-1 gene delivery reveals reduced mortality and preservation of left ventricular function 1 yr after acute myocardial infarction. Am J Physiol Heart Circ Physiol. 2007;293(1):H48\u201359. https:\/\/doi.org\/10.1152\/ajpheart.00741.2006.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"7590_CR9","doi-asserted-by":"publisher","unstructured":"Li, Q., Guo, Y., Ou, Q., et al. Gene transfer as a strategy to achieve permanent cardioprotection II: rAAV-mediated gene therapy with heme oxygenase-1 limits infarct size 1 year later without adverse functional consequences. Basic Res Cardiol, 106(6), 1367\u20131377. https:\/\/doi.org\/10.1007\/s00395-011-0208-6","DOI":"10.1007\/s00395-011-0208-6"},{"issue":"2","key":"7590_CR10","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.jacc.2015.04.064","volume":"66","author":"R Hinkel","year":"2015","unstructured":"Hinkel R, Lange P, Petersen B, et al. Heme oxygenase-1 gene therapy provides cardioprotection via control of post-ischemic inflammation: an experimental study in a pre-clinical pig model. J Am College Cardiol. 2015;66(2):154\u201365. https:\/\/doi.org\/10.1016\/j.jacc.2015.04.064.","journal-title":"J Am College Cardiol"},{"issue":"12","key":"7590_CR11","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1161\/CIRCRESAHA.116.306588","volume":"118","author":"LE Otterbein","year":"2016","unstructured":"Otterbein LE, Foresti R, Motterlini R. Heme oxygenase-1 and carbon monoxide in the heart: the balancing act between danger signaling and pro-survival. Circ Res. 2016;118(12):1940\u201359. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.306588.","journal-title":"Circ Res"},{"issue":"2","key":"7590_CR12","doi-asserted-by":"publisher","first-page":"e2","DOI":"10.1161\/01.RES.0000084381.86567.08","volume":"93","author":"JE Clark","year":"2003","unstructured":"Clark JE, Naughton P, Shurey S, et al. Cardioprotective actions by a water-soluble carbon monoxide-releasing molecule. Circ Res. 2003;93(2):e2\u20138. https:\/\/doi.org\/10.1161\/01.RES.0000084381.86567.08.","journal-title":"Circ Res"},{"issue":"2","key":"7590_CR13","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1161\/01.atv.16.2.250","volume":"16","author":"PN Hopkins","year":"1996","unstructured":"Hopkins PN, Wu LL, Hunt SC, et al. Higher serum bilirubin is associated with decreased risk for early familial coronary artery disease. Arteriosclerosis Thrombosis Vasc Biol. 1996;16(2):250\u20135. https:\/\/doi.org\/10.1161\/01.atv.16.2.250.","journal-title":"Arteriosclerosis Thrombosis Vasc Biol"},{"issue":"4","key":"7590_CR14","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.carpath.2014.03.007","volume":"23","author":"MA Allwood","year":"2014","unstructured":"Allwood MA, Kinobe RT, Ballantyne L, et al. Heme oxygenase-1 overexpression exacerbates heart failure with aging and pressure overload but is protective against isoproterenol-induced cardiomyopathy in mice. Cardiovasc Pathol\u202f: Official J Soc Cardiovasc Pathol. 2014;23(4):231\u20137. https:\/\/doi.org\/10.1016\/j.carpath.2014.03.007.","journal-title":"Cardiovasc Pathol : Official J Soc Cardiovasc Pathol"},{"issue":"17","key":"7590_CR15","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1161\/CIRCULATIONAHA.109.905471","volume":"121","author":"G Wang","year":"2010","unstructured":"Wang G, Hamid T, Keith RJ, et al. Cardioprotective and antiapoptotic effects of heme oxygenase-1 in the failing heart. Circulation. 2010;121(17):1912\u201325. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.109.905471.","journal-title":"Circulation"},{"issue":"1","key":"7590_CR16","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1086\/302729","volume":"66","author":"N Yamada","year":"2000","unstructured":"Yamada N, Yamaya M, Okinaga S, et al. Microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with susceptibility to emphysema. Am J Human Gen. 2000;66(1):187\u201395.","journal-title":"Am J Human Gen"},{"key":"7590_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00439-002-0769-4","volume":"111","author":"YH Chen","year":"2014","unstructured":"Chen YH, Lin SJ, Lin MW, et al. Microsatellite polymorphism in promoter of heme oxygenase-1 gene is associated with susceptibility to coronary artery disease in type 2 diabetic patients. Human genetics. 2014;111:1\u20138.","journal-title":"Human genetics"},{"issue":"5","key":"7590_CR18","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1177\/152660280100800501","volume":"8","author":"M Exner","year":"2001","unstructured":"Exner M, Schillinger M, Minar E, et al. Heme oxygenase-1 gene promoter microsatellite polymorphism is associated with restenosis after percutaneous transluminal angioplasty. J Endovasc Ther. 2001;8(5):433\u201340.","journal-title":"J Endovasc Ther"},{"issue":"8","key":"7590_CR19","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1093\/eurheartj\/ehm036","volume":"28","author":"K Tiroch","year":"2007","unstructured":"Tiroch K, Koch W, von Beckerath N, et al. Heme oxygenase-1 gene promoter polymorphism and restenosis following coronary stenting. Euro Heart J. 2007;28(8):968\u201373.","journal-title":"Euro Heart J"},{"issue":"4","key":"7590_CR20","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1111\/j.1600-6143.2006.01726.x","volume":"7","author":"AE Courtney","year":"2007","unstructured":"Courtney AE, McNamee PT, Middleton D, et al. Association of functional heme oxygenase-1 gene promoter polymorphism with renal transplantation outcomes. Am J Transpl. 2007;7(4):908\u201313.","journal-title":"Am J Transpl"},{"issue":"2","key":"7590_CR21","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.atherosclerosis.2003.11.021","volume":"173","author":"K Ono","year":"2004","unstructured":"Ono K, Goto Y, Takagi S, et al. A promoter variant of the heme oxygenase-1 gene may reduce the incidence of ischemic heart disease in Japanese. Atherosclerosis. 2004;173(2):313\u20137.","journal-title":"Atherosclerosis"},{"issue":"1","key":"7590_CR22","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.tips.2015.09.003","volume":"37","author":"NG Abraham","year":"2016","unstructured":"Abraham NG, Junge JM, Drummond GS. Translational Significance of Heme Oxygenase in Obesity and Metabolic Syndrome. Trends Pharmacol Sci. 2016;37(1):17\u201336. https:\/\/doi.org\/10.1016\/j.tips.2015.09.003.","journal-title":"Trends Pharmacol Sci"},{"issue":"1","key":"7590_CR23","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1161\/ATVBAHA.114.304729","volume":"35","author":"R Pechlaner","year":"2015","unstructured":"Pechlaner R, Willeit P, Summerer M, et al. Heme oxygenase-1 gene promoter microsatellite polymorphism is associated with progressive atherosclerosis and incident cardiovascular disease. Arteriosclerosis, Thrombosis Vasc Biol. 2015;35(1):229\u201336.","journal-title":"Arteriosclerosis, Thrombosis Vasc Biol"},{"issue":"21","key":"7590_CR24","doi-asserted-by":"publisher","first-page":"11629","DOI":"10.3390\/ijms222111629","volume":"22","author":"J Guti\u00e9rrez-Cuevas","year":"2021","unstructured":"Guti\u00e9rrez-Cuevas J, Santos A, Armendariz-Borunda J. Pathophysiological Molecular Mechanisms of Obesity: A Link between MAFLD and NASH with Cardiovascular Diseases. Int J Mol Sci. 2021;22(21):11629. https:\/\/doi.org\/10.3390\/ijms222111629.","journal-title":"Int J Mol Sci."},{"issue":"6","key":"7590_CR25","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1161\/01.RES.0000091828.36599.34","volume":"93","author":"NG Abraham","year":"2003","unstructured":"Abraham NG, Kushida T, McClung J, et al. Heme oxygenase-1 attenuates glucose-mediated cell growth arrest and apoptosis in human microvessel endothelial cells. Circulation Research. 2003;93(6):507\u201314.","journal-title":"Circulation Research"},{"issue":"1","key":"7590_CR26","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1124\/pr.107.07104","volume":"60","author":"NG Abraham","year":"2008","unstructured":"Abraham NG, Kappas A. Pharmacological and clinical aspects of heme oxygenase. Pharmacol Rev. 2008;60(1):79\u2013127.","journal-title":"Pharmacol Rev"},{"issue":"3","key":"7590_CR27","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1159\/000154819","volume":"6","author":"NG Abraham","year":"1996","unstructured":"Abraham NG, Drummond GS, Lutton JD, et al. The biological significance and physiological role of heme oxygenase. Cell Physiol Biochem. 1996;6(3):129\u201368.","journal-title":"Cell Physiol Biochem"},{"issue":"5","key":"7590_CR28","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1172\/JCI448","volume":"101","author":"PA Dennery","year":"1998","unstructured":"Dennery PA, Spitz DR, Yang G, et al. Oxygen toxicity and iron accumulation in the lungs of mice lacking heme oxygenase-2. J Clin Investig. 1998;101(5):1001\u201311.","journal-title":"J Clin Investig"},{"issue":"4","key":"7590_CR29","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1681\/ASN.2004121082","volume":"17","author":"AI Goodman","year":"2006","unstructured":"Goodman AI, Chander PN, Rezzani R, et al. Heme oxygenase-2 deficiency contributes to diabetes-mediated increase in superoxide anion and renal dysfunction. J Am Soc Nephrol. 2006;17(4):1073\u201381.","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"7590_CR30","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1124\/jpet.109.157545","volume":"331","author":"K Sodhi","year":"2009","unstructured":"Sodhi K, Inoue K, Gotlinger KH, et al. Epoxyeicosatrienoic acid agonist rescues the metabolic syndrome phenotype of HO-2-null mice. J Pharmacol Exp Therap. 2009;331(3):906\u201316.","journal-title":"J Pharmacol Exp Therap"},{"issue":"7","key":"7590_CR31","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/j.metabol.2006.02.022","volume":"55","author":"CK Roberts","year":"2006","unstructured":"Roberts CK, Barnard RJ, Sindhu RK, et al. Oxidative stress and dysregulation of NAD (P) H oxidase and antioxidant enzymes in diet-induced metabolic syndrome. Metabolism. 2006;55(7):928\u201334.","journal-title":"Metabolism"},{"issue":"3","key":"7590_CR32","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.bbrc.2006.03.036","volume":"343","author":"M Hsu","year":"2006","unstructured":"Hsu M, Muchova L, Morioka I, et al. Tissue-specific effects of statins on the expression of heme oxygenase-1 in vivo. Biochem Biophys Res Commun. 2006;343(3):738\u201344. https:\/\/doi.org\/10.1016\/j.bbrc.2006.03.036.","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"7590_CR33","doi-asserted-by":"publisher","first-page":"R207","DOI":"10.1152\/ajpregu.00517.2011","volume":"302","author":"PA Hosick","year":"2012","unstructured":"Hosick PA, Stec DE. Heme oxygenase, a novel target for the treatment of hypertension and obesity? Am J Physiol Reg, Integr Comp Physiol. 2012;302(2):R207\u201314.","journal-title":"Am J Physiol Reg, Integr Comp Physiol"},{"issue":"6","key":"7590_CR34","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1161\/HYPERTENSIONAHA.110.151423","volume":"56","author":"A Burgess","year":"2010","unstructured":"Burgess A, Li M, Vanella L, Kim DH, et al. Adipocyte heme oxygenase-1 induction attenuates metabolic syndrome in both male and female obese mice. Hypertension. 2010;56(6):1124\u201330.","journal-title":"Hypertension"},{"issue":"2","key":"7590_CR35","doi-asserted-by":"publisher","first-page":"e55369","DOI":"10.1371\/journal.pone.0055369","volume":"8","author":"JY Huang","year":"2013","unstructured":"Huang JY, Chiang MT, Chau LY. Adipose overexpression of heme oxygenase-1 does not protect against high fat diet-induced insulin resistance in mice. PLoS One. 2013;8(2):e55369.","journal-title":"PLoS One"},{"key":"7590_CR36","doi-asserted-by":"publisher","first-page":"H2468","DOI":"10.1152\/ajpheart.01187.2003","volume":"287","author":"NG Abraham","year":"2004","unstructured":"Abraham NG, Rezzani R, Rodella L, et al. Overexpression of human heme oxygenase-1 attenuates endothelial cell sloughing in experimental diabetes. Am J Physiol Heart Circ Physiol. 2004;287:H2468\u201377.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"7590_CR37","doi-asserted-by":"crossref","unstructured":"Drummond HA, Mitchell ZL, Abraham NG, et al. Targeting heme oxygenase-1 in cardiovascular and kidney disease. Antioxidants (Basel). 2019 8.","DOI":"10.3390\/antiox8060181"},{"issue":"3","key":"7590_CR38","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/ki.2012.102","volume":"82","author":"J Kim","year":"2012","unstructured":"Kim J, Zarjou A, Traylor AM, et al. In vivo regulation of the heme oxygenase-1 gene in humanized transgenic mice. Kidney Int. 2012;82(3):278\u201391. https:\/\/doi.org\/10.1038\/ki.2012.102.","journal-title":"Kidney Int."},{"key":"7590_CR39","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1681\/ASN.V115965","volume":"11","author":"A Agarwal","year":"2000","unstructured":"Agarwal A, Nick HS. Renal response to tissue injury: lessons from heme oxygenase-1 gene ablation and expression. J Am Soc Nephrol. 2000;11:965\u201373.","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"7590_CR40","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1124\/mol.61.3.554","volume":"61","author":"G Scapagnini","year":"2002","unstructured":"Scapagnini G, Foresti R, Calabrese V, et al. Caffeic acid phenethyl ester and curcumin: a novel class of heme oxygenase-1 inducers. Mol Pharmacol. 2002;61(3):554\u201361. https:\/\/doi.org\/10.1124\/mol.61.3.554.","journal-title":"Mol Pharmacol"},{"issue":"25","key":"7590_CR41","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.1016\/j.lfs.2005.11.013","volume":"78","author":"CC Wu","year":"2006","unstructured":"Wu CC, Hsu MC, Hsieh CW, et al. Upregulation of heme oxygenase-1 by Epigallocatechin-3-gallate via the phosphatidylinositol 3-kinase\/Akt and ERK pathways. Life sciences. 2006;78(25):2889\u201397. https:\/\/doi.org\/10.1016\/j.lfs.2005.11.013.","journal-title":"Life sciences"},{"issue":"10","key":"7590_CR42","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1161\/01.CIR.0000140694.67251.9C","volume":"110","author":"TS Lee","year":"2004","unstructured":"Lee TS, Chang CC, Zhu Y, et al. Simvastatin induces heme oxygenase-1: a novel mechanism of vessel protection. Circulation. 2004;110(10):1296\u2013302. https:\/\/doi.org\/10.1161\/01.CIR.0000140694.67251.9C.","journal-title":"Circulation"},{"issue":"1","key":"7590_CR43","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.cellsig.2005.03.016","volume":"18","author":"JC Chen","year":"2006","unstructured":"Chen JC, Huang KC, Lin WW. HMG-CoA reductase inhibitors upregulate heme oxygenase-1 expression in murine RAW264.7 macrophages via ERK, p38 MAPK and protein kinase G pathways. Cell Sign. 2006;18(1):32\u20139. https:\/\/doi.org\/10.1016\/j.cellsig.2005.03.016.","journal-title":"Cell Sign"},{"issue":"4","key":"7590_CR44","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/s0006-291x(03)01504-3","volume":"308","author":"N Grosser","year":"2003","unstructured":"Grosser N, Abate A, Oberle S, et al. Heme oxygenase-1 induction may explain the antioxidant profile of aspirin. Biochem Biophys Res Commun. 2003;308(4):956\u201360. https:\/\/doi.org\/10.1016\/s0006-291x(03)01504-3.","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"7590_CR45","doi-asserted-by":"publisher","first-page":"103","DOI":"10.5414\/cnp58103","volume":"58","author":"L Cal\u00f2","year":"2002","unstructured":"Cal\u00f2 L, Giacon B, Davis PA, et al. Oxidative stress and TGFbeta in kidney-transplanted patients with cyclosporin-induced hypertension Effect of carvedilol and nifedipine. Clinical Nephrol. 2002;58(2):103\u201310. https:\/\/doi.org\/10.5414\/cnp58103.","journal-title":"Clinical Nephrol"},{"key":"7590_CR46","doi-asserted-by":"publisher","first-page":"103198","DOI":"10.1016\/j.etap.2019.103198","volume":"70","author":"MMM Refaie","year":"2019","unstructured":"Refaie MMM, El-Hussieny M, et al. Mechanisms mediating the cardioprotective effect of carvedilol in cadmium induced cardiotoxicity Role of eNOS and HO1\/Nrf2 pathway. Environ Toxicol Pharmacol. 2019;70:103198. https:\/\/doi.org\/10.1016\/j.etap.2019.103198.","journal-title":"Environ Toxicol Pharmacol"},{"issue":"4","key":"7590_CR47","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1084\/jem.20052321","volume":"203","author":"BJ Wu","year":"2006","unstructured":"Wu BJ, Kathir K, Witting PK, et al. Antioxidants protect from atherosclerosis by a heme oxygenase-1 pathway that is independent of free radical scavenging. J Exp Med. 2006;203(4):1117\u201327. https:\/\/doi.org\/10.1084\/jem.20052321.","journal-title":"J Exp Med"},{"issue":"1","key":"7590_CR48","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.bbrc.2004.06.120","volume":"321","author":"BM Choi","year":"2004","unstructured":"Choi BM, Kim YM, Jeong YR, et al. Induction of heme oxygenase-1 is involved in anti-proliferative effects of paclitaxel on rat vascular smooth muscle cells. Biochem Biophys Res Commun. 2004;321(1):132\u20137. https:\/\/doi.org\/10.1016\/j.bbrc.2004.06.120.","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"7590_CR49","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1161\/01.cir.0000048191.75585.60","volume":"107","author":"GA Visner","year":"2003","unstructured":"Visner GA, Lu F, et al. Rapamycin induces heme oxygenase-1 in human pulmonary vascular cells: implications in the antiproliferative response to rapamycin. Circulation. 2003;107(6):911\u20136. https:\/\/doi.org\/10.1161\/01.cir.0000048191.75585.60.","journal-title":"Circulation"},{"key":"7590_CR50","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1161\/HYPERTENSIONAHA.110.151423","volume":"56","author":"A Burgess","year":"2010","unstructured":"Burgess A, Li M, Vanella L, et al. Adipocyte heme oxygenase-1 induction attenuates metabolic syndrome in both male and female obese mice. Hypertension. 2010;56:1124\u201330.","journal-title":"Hypertension"},{"key":"7590_CR51","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.2337\/db07-1764","volume":"57","author":"M Li","year":"2008","unstructured":"Li M, Kim DH, Tsenovoy PL, Peterson SJ, Rezzani R, Rodella LF, Aronow WS, Ikehara S, Abraham NG. Treatment of obese diabetic mice with a heme oxygenase inducer reduces visceral and subcutaneous adiposity, increases adiponectin levels, and improves insulin sensitivity and glucose tolerance. Diabetes. 2008;57:1526\u201335.","journal-title":"Diabetes"},{"key":"7590_CR52","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1089\/hum.2010.059","volume":"22","author":"J Cao","year":"2011","unstructured":"Cao J, Sodhi K, Inoue K, et al. Lentiviral-human heme oxygenase targeting endothelium improved vascular function in angiotensin II animal model of hypertension. Hum Gene Ther. 2011;22:271\u201382.","journal-title":"Hum Gene Ther"},{"issue":"10","key":"7590_CR53","doi-asserted-by":"publisher","first-page":"2514","DOI":"10.3390\/ijms20102514","volume":"20","author":"SJ Peterson","year":"2019","unstructured":"Peterson SJ, Rubinstein R, Faroqui M, et al. Positive Effects of Heme Oxygenase Upregulation on Adiposity and Vascular Dysfunction: Gene Targeting vs. Pharmacologic Therapy. Int J Mol Sc. 2019;20(10):2514. https:\/\/doi.org\/10.3390\/ijms20102514.","journal-title":"Int J Mol Sc"},{"key":"7590_CR54","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/ijo.2011.78","volume":"36","author":"E Csongradi","year":"2012","unstructured":"Csongradi E, Docarmo JM, Dubinion JH, et al. Chronic HO-1 induction with cobalt protoporphyrin (CoPP) treatment increases oxygen consumption, activity, heat production and lowers body weight in obese melanocortin-4 receptor-deficient mice. Int J Obes (Lond). 2012;36:244\u201353.","journal-title":"Int J Obes (Lond)"},{"issue":"2","key":"7590_CR55","doi-asserted-by":"publisher","first-page":"277","DOI":"10.18388\/abp.2017_2542","volume":"65","author":"O Mucha","year":"2018","unstructured":"Mucha O, Podkalicka P, Czarnek M, et al. Pharmacological versus genetic inhibition of heme oxygenase-1 - the comparison of metalloporphyrins, shRNA and CRISPR\/Cas9 system. Acta Biochim Pol. 2018;65(2):277\u201386. https:\/\/doi.org\/10.18388\/abp.2017_2542.","journal-title":"Acta Biochim Pol"},{"issue":"11","key":"7590_CR56","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.3389\/fimmu.2020.01467","volume":"23","author":"SC Funes","year":"2020","unstructured":"Funes SC, Rios M, Fern\u00e1ndez-Fierro A, et al. Naturally Derived Heme-Oxygenase 1 Inducers and Their Therapeutic Application to Immune-Mediated Diseases. Front Immunol. 2020;23(11):1467. https:\/\/doi.org\/10.3389\/fimmu.2020.01467.","journal-title":"Front Immunol"},{"issue":"3","key":"7590_CR57","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1160\/TH12-05-0303","volume":"108","author":"W Wojakowski","year":"2012","unstructured":"Wojakowski W, Tendera M, Cybulski W, et al. Effects of intracoronary delivery of allogenic bone marrow-derived stem cells expressing heme oxygenase-1 on myocardial reperfusion injury. Thromb Haemost. 2012;108(3):464\u201375. https:\/\/doi.org\/10.1160\/TH12-05-0303.","journal-title":"Thromb Haemost"},{"issue":"3","key":"7590_CR58","doi-asserted-by":"publisher","first-page":"381","DOI":"10.3390\/biom10030381","volume":"10","author":"C-M Yang","year":"2020","unstructured":"Yang C-M, Lin C-C, Yang C-C, et al. Mevastatin-Induced AP-1-Dependent HO-1 Expression Suppresses Vascular Cell Adhesion Molecule-1 Expression and Monocyte Adhesion on Human Pulmonary Alveolar Epithelial Cells Challenged with TNF-\u03b1. Biomolecules. 2020;10(3):381. https:\/\/doi.org\/10.3390\/biom10030381.","journal-title":"Biomolecules"},{"key":"7590_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2019.108073","volume":"673","author":"GS Drummond","year":"2019","unstructured":"Drummond GS, Baum J, Greenberg M, et al. HO-1 overexpression and underexpression: clinical implications. Arch Biochem Biophys. 2019;673: 108073.","journal-title":"Arch Biochem Biophys"},{"key":"7590_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.trim.2021.101419","volume":"68","author":"M Verheij","year":"2021","unstructured":"Verheij M, Zeerleder S, Voermans C. Heme oxygenase-1: Equally important in allogeneic hematopoietic stem cell transplantation and organ transplantation? Transpl Immunol. 2021;68: 101419. https:\/\/doi.org\/10.1016\/j.trim.2021.101419.","journal-title":"Transpl Immunol"},{"key":"7590_CR61","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s13287-016-0427-8","volume":"7","author":"Y Yang","year":"2016","unstructured":"Yang Y, Song H, Zhang W, et al. Heme oxygenase-1-transduced bone marrow mesenchymal stem cells in reducing acute rejection and improving small bowel transplantation outcomes in rats. Stem Cell Res Ther. 2016;7:164. https:\/\/doi.org\/10.1186\/s13287-016-0427-8.","journal-title":"Stem Cell Res Ther"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-024-07590-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10557-024-07590-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-024-07590-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T07:01:08Z","timestamp":1766127668000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10557-024-07590-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,28]]},"references-count":61,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["7590"],"URL":"https:\/\/doi.org\/10.1007\/s10557-024-07590-0","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,28]]},"assertion":[{"value":"24 May 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable as it is a review article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable as it is a review article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}